True

Mathias Schmidt(Essen University Hospital), John Mendelsohn(Unknown)
British Journal of Cancer
January 1, 2000
10.1054/bjoc.2000.1201
Cited by 127

Related Papers

Phase I Studies of Anti–Epidermal Growth Factor Receptor Chimeric Antibody C225 Alone and in Combination With Cisplatin
|Journal of Clinical Oncology|2000|746
The epidermal growth factor receptor as a target for cancer therapy.
|Endocrine Related Cancer|2001|331
Molecular alterations in apoptotic pathways after PKB/Akt-mediated chemoresistance in NCI H460 cells
|British Journal of Cancer|2004|57
A novel form of constitutively active farnesylated Akt1 prevents mammary epithelial cells from anoikis and suppresses chemotherapy-induced apoptosis
|British Journal of Cancer|2002|48
Understanding continent-wide variation in vulture ranging behavior to assess feasibility of Vulture Safe Zones in Africa: Challenges and possibilities
|Biological Conservation|2022|23